ANTX (STOCKS)
AN2 Therapeutics, Inc. Common Stock
$6.300000
+0.020000 (+0.32%)
Prev close: $6.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric Easom
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $254.40M
- Employees
- 36
- P/E (TTM)
- -5.85
- P/B (TTM)
- 3.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Assets | $81.68M |
| Current Assets | $79.99M |
| Noncurrent Assets | $1.69M |
| Liabilities | $5.76M |
| Current Liabilities | $5.59M |
| Accounts Payable | $1.97M |
| Wages | $1.10M |
| Other Current Liabilities | $2.52M |
| Noncurrent Liabilities | $170.00K |
| Equity | $75.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $75.92M |
| Liabilities And Equity | $81.68M |